콘텐츠로 건너뛰기
온라인 영업 엔지니어 · 09:00~21:00 CST 바오안, 선전, 중국
집/소식/로봇공학 및 AI
로봇공학 및 AI

국산 수술로봇 첫 상용화 이후 다빈치 로봇은 어디로 갈까?

국가 의약품 안전청은 "복강경 수술 시스템"의 임상 적용 범위를 변경했습니다.

국산 수술로봇 첫 상용화 이후 다빈치 로봇은 어디로 갈까?

The State Drug Administration has changed the scope of clinical application of the "Laparoscopic Surgical System". It is reported that recently, after the hospital's rigorous procurement plan, approval and bidding, this robot® has been installed in the First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine.수술용 로봇다빈치 수술로봇 시리즈가 만들어낸 다양한 적응증과 전설적인 금흡수 역사로 인해 내시경 수술로봇은 늘 자본의 큰 기대를 받아왔고, 국내 다빈치에게도 필수품이다.

According to the statistics of the International Federation of Robotics, in 2020, endoscopic surgical robots will swallow up 63% of the global market in the field of surgical robots. However, there is a stark and sharp contrast between the fervor of capital and the difficulty of commercialization, and surgical robots are inevitable. experienced ups and downs. When enterprises have passed the three hurdles of landing, financing, and obtaining certificates, they will usher in an era of commercialization with more brutal competition.

수술용 로봇최초의 상업용 설치:

After ten years of independent research and development, innovation and improvement, the first domestic open doctor console three-arm laparoscopic surgery robot approved by the NMPA for listing - the laparoscopic surgery system has achieved the first commercial installation in China. According to reports, intraperitoneal The speculum surgery system is a laparoscopic surgery robot designed for various complex minimally invasive surgeries. It has significant advantages over traditional laparoscopic surgery in terms of precise operation, elimination of tremor, and improvement of doctor's comfort.

Adapted to its own and mainstream 3D high-definition endoscope systems at home and abroad, it enables surgeons to obtain real-time surgical field of view through endoscopes, accurately touch the surgical area in complex surgical environments, and control the operation area of patients through the master-slave control system. Completely reproduce the doctor's operation intention.

The device is a product of Suzhou Kangduo Robotics Co., Ltd., a wholly-owned subsidiary of Harbin Sagerui Intelligent Medical Equipment Co., Ltd. It is understood that Harbin Sagerui Intelligent Medical Equipment Co., Ltd. is a high-tech enterprise focusing on the research and development, production and sales of surgical robots. Since its establishment, the company has always insisted on independent innovation and strived to break the monopoly of foreign products.

약 10년의 개발 끝에 수술로봇 분야에서는 탐구와 축적을 통해 일련의 핵심기술과 독창적인 성과를 이루었습니다.

Minimally Invasive Robotics와 Jingfeng Medical의 내시경 수술 로봇의 승인으로 중국 내시경 수술 로봇의 다공 분야는 "1(수입) + 4(국내)"의 경쟁 패턴을 형성했습니다.

It is worth mentioning that this installation is a high recognition of the technical strength of the equipment and the training service system by the hospital and the market. It is also an important milestone for the domestic surgical robot with independent intellectual property rights from research and development to commercial transformation. The installation of Taiwan's domestic laparoscopic robot is of great significance to the development and popularization of domestic surgical robots.수술용 로봇국내 다빈치의 상용화 딜레마:

많은 수술용 로봇이 '다빈치 대비'라는 기치 아래 있지만, 지난 20년 동안 수술용 로봇의 상용화 궤도에서 다빈치의 미등을 본 기업은 거의 없다.

1997년 1세대 다빈치 로봇수술 시스템 개발에 성공했고, 2000년 7월 미국 FDA 인증을 통과해 임상에 적용됐다. 최근에는 다빈치 수술로봇의 대성공으로 수술로봇의 대명사가 됐다.

Although the da Vinci surgical robot is currently the most successful and widely used surgical robot in the world, it is extremely expensive. According to public data, the domestic price of the da Vinci surgical system (complete machine) is about 20 million yuan, including the wire-driven mechanical operation arm as a consumable, each limited to ten times of use, and the replacement of a single arm costs tens of thousands of yuan. Therefore, the domestic use of Da Vinci for surgery costs at least 50,000 to 100,000 yuan.

The da Vinci surgical system is a major product in the global endoscopic surgery robotics market. As of September 30, 2021, the United States is the largest endoscopic surgical robot market, with 4,005 installed da Vinci surgical systems, accounting for 61.4% of the global installed base. Despite China's large patient population and the large number of traditional minimally invasive surgeries that can potentially be performed using surgical robots, the market penetration rate of laparoscopic surgical robots in China is significantly lower than that of the US market.

중국에 설치된 다빈치 수술 시스템의 수는 약 240개에 불과해 전 세계 설치의 3.7%를 차지하며, 3차 병원 중 다빈치 수술 시스템을 채택한 곳은 10% 미만이다.

After 2010, global surgery has entered the era of robots, and many domestic robot projects have begun to enter clinical practice. The orthopedic robot navigation and positioning system independently developed by Tianzhihang Company, a representative domestic company, has obtained the first NMPA registration license for domestic robots. After 2015, the research and development of surgical robots in various departments in China has entered a state of flourishing, the industry has become more and more vigorous, and domestic surgical robots have become more professional.

The Chinese government has promulgated a series of regulations in recent years to promote the development of innovative medical devices such as surgical robots. In April 2021, the Da Vinci Surgical System was included in the Shanghai medical insurance reimbursement list, showing the government's recognition of the importance of endoscopic surgery robots. More endoscopic surgical robot products may also be included in the medical insurance reimbursement list, further opening up the Chinese endoscopic surgery system. Surgical Robotics Market.

수술용 로봇결론:

Due to the characteristics of long research and development time, large capital investment, and long payback time, surgical robots have always been a huge consumption project, and they are like gold-eating beasts under the scientific research of time and financial resources. Looking back at 2022, surgical robots have experienced a night of cold wind, and they have also suffered from losses. Now that the sale of surgical robot has been officially completed, and the installation of the first commercial domestic laparoscopic robot, we have reason to believe that this pearl will eventually shine brightly.

수술용 로봇, 의료용 로봇, 임상용 로봇

귀하의 회선에 대해 이를 지정해야 합니까?부품, 목표 속도 및 국가를 보내면 엔지니어가 48시간 이내에 응답합니다.

견적 요청
관련된

더 많은 기사

TROY 어시스턴트영업 엔지니어 · 몇 초 만에 답변
안녕하세요. 저는 TROY의 영업엔지니어 봇입니다.
자동화에 필요한 것이 무엇인지 알려주십시오. 부품 중량, 도달 범위 또는 사이클 시간이면 충분합니다. 나는 귀하의 언어로 답변하고 48시간 안에 인간 엔지니어 앞에 귀하를 연결해 드릴 수 있습니다.
가격은 공개되지 않습니다. 48시간 이내에 구성별 견적 ·견적 양식